Please wait while the formulary information is being retrieved.
3 DAY VAGINAL (MICONAZOLE NITRATE)
- Vulvovaginal candidiasis
Miconazole-3 200 mg/5 gram (4 %) vaginal cream
- Dosage information is not available
200 mg/5 gram (4 %) cream
- Dosage information is not available
- Detrol La
- tolterodine
Contraindicated
- Astagraf Xl
- Coumadin
- cyclosporine
- cyclosporine modified
- Gengraf
- Hecoria
- Jantoven
- Neoral
- Prograf
- Rapamune
- Sandimmune
- sirolimus
- tacrolimus
- temsirolimus
- Torisel
- warfarin
Severe
Moderate
- Amaryl
- Detrol
- Diabeta
- Duetact
- glimepiride
- glipizide
- glipizide-metformin
- Glucotrol
- Glucotrol Xl
- Glucovance
- glyburide
- glyburide micronized
- glyburide-metformin
- Glynase
- isoniazid-rifamp-pyrazinamide
- Mycobutin
- pioglitazone-glimepiride
- Priftin
- rifabutin
- Rifadin
- Rifamate
- rifampin
- rifampin-isoniazid
- rifapentine
- Rifater
- tolazamide
- tolbutamide
- None
Contraindicated
- None
Severe
Moderate
- No disease contraindications
3 DAY VAGINAL (MICONAZOLE NITRATE)
- Vulvovaginal candidiasis
- None
- None
More Frequent
Severe
Less Severe
- None
- Dysmenorrhea
- Fever
- Genital organ pruritus
- Vaginal discharge
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Bronchospastic pulmonary disease
- Toxic epidermal necrolysis
- Urticaria
Less Severe
- Abdominal pain with cramps
- Chills
- Contact dermatitis
- Dizziness
- Facial edema
- Flu-like symptoms
- General weakness
- Headache disorder
- Pruritus of skin
- Skin rash
- Vaginal burning
- Vaginal irritation
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Miconazole (vag)
- Severity Level:
C
- Additional Notes: Mfr does not rec use in 1st trimester, small amount is absorbed through vagina
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Miconazole
Insufficient human data; poor oral absorption
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data; poor oral absorption |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Vulvovaginal candidiasis | |
| B37.3 | Candidiasis of vulva and vagina |
| 0-9 | A-Z |
|---|---|
| B37.3 | Candidiasis of vulva and vagina |
Formulary Reference Tool